{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:19:17Z","timestamp":1789510757071,"version":"build-2803163510"},"reference-count":64,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease (CKD), especially diabetic kidney disease (DKD), is characterized not only by progressive loss of renal function but also by profound metabolic disturbances, including insulin resistance (IR). Emerging evidence implicates gut-derived uremic toxins as mediators linking intestinal dysbiosis to metabolic and renal injury. Several microbial metabolites, for example, indoxyl sulfate, p-cresyl sulfate, and trimethylamine-N-oxide, are known to accumulate in CKD due to decreased renal excretion and altered tubular secretion. In vitro and in vivo experiments indicate that these gut-derived nephrotoxins impair insulin signaling pathways in cells. This results in increased production of reactive oxygen species, activation of stress kinases, higher levels of inflammatory cytokines, and inhibitory serine phosphorylation of insulin receptor substrates. Consequently, phosphatidylinositol 3-kinase (PI3K)\/protein kinase B (Akt) signaling is impaired, reducing cellular glucose uptake. At the same time, these toxins induce endothelial dysfunction and mitochondrial damage, not only causing systemic IR but also contributing to the progression of kidney disease. Observational data link higher plasma toxin levels with components of IR, rapid loss of renal function as measured by estimated glomerular filtration rate, and a high risk of cardiovascular events in CKD patients. Although causality in humans remains unproven, interventions targeting the microbiota, toxin binding, and oxidative stress pathways show promise. We propose an integrated gut\u2013kidney\u2013metabolic framework in which dysbiosis-driven toxin production may amplify IR and DKD progression.<\/jats:p>","DOI":"10.3390\/ijms27083472","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:19:14Z","timestamp":1776075554000},"page":"3472","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Gut\u2013Kidney\u2013Metabolic Axis: Impact of Gut-Derived Uremic Toxins on Insulin Resistance in Diabetic Kidney Disease"],"prefix":"10.3390","volume":"27","author":[{"given":"Charlotte","family":"Delrue","sequence":"first","affiliation":[{"name":"Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Vinckier","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3546","authenticated-orcid":false,"given":"Reinhart","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-1630","authenticated-orcid":false,"given":"Stefania","family":"Marzocco","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-4390","authenticated-orcid":false,"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium"},{"name":"Research Foundation-Flanders (FWO), 1000 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lim, Y.J., Sidor, N.A., Tonial, N.C., Che, A., and Urquhart, B.L. (2021). Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Toxins, 13.","DOI":"10.3390\/toxins13020142"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101484","DOI":"10.1016\/j.beem.2021.101484","article-title":"Intestinal Microbiota and Diabetic Kidney Diseases: The Role of Microbiota and Derived Metabolites Inmodulation of Renal Inflammation and Disease Progression","volume":"35","author":"Mosterd","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rysz, J., Franczyk, B., \u0141awi\u0144ski, J., Olszewski, R., Cia\u0142kowska-Rysz, A., and Gluba-Brz\u00f3zka, A. (2021). The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins, 13.","DOI":"10.3390\/toxins13040252"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"112440","DOI":"10.4239\/wjd.v16.i11.112440","article-title":"Unveiling the Gut-Kidney Dialogue in Diabetic Kidney Disease","volume":"16","author":"Gembillo","year":"2025","journal-title":"World J. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rusu, M., Ichim, C., Anderco, P., P\u0103l\u0103\u0219tea, A., and Boicean, A. (2026). Gut-Kidney Axis: Unraveling the Role of the Microbiome in Chronic Kidney Disease. Biomedicines, 14.","DOI":"10.3390\/biomedicines14010109"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tsuji, K., Uchida, N., Nakanoh, H., Fukushima, K., Haraguchi, S., Kitamura, S., and Wada, J. (2024). The Gut\u2013Kidney Axis in Chronic Kidney Diseases. Diagnostics, 15.","DOI":"10.20944\/preprints202411.1338.v1"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nakashima, A., Kato, K., Ohkido, I., and Yokoo, T. (2021). Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. Nutrients, 13.","DOI":"10.3390\/nu13124349"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","article-title":"Insulin Resistance in Patients with Chronic Kidney Disease","volume":"45","author":"Kobayashi","year":"2005","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"691369","DOI":"10.1155\/2012\/691369","article-title":"Insulin Resistance in Patients with Chronic Kidney Disease","volume":"2012","author":"Liao","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.2015.305","article-title":"Molecular Mechanisms of Insulin Resistance in Chronic Kidney Disease","volume":"88","author":"Thomas","year":"2015","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1038\/s41598-025-87501-x","article-title":"Hypoglycemia and Hyperinsulinemia Induced by Phenolic Uremic Toxins in CKD and DKD Patients","volume":"15","author":"Tongu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/j.2040-4603.2023.tb00281.x","article-title":"Insulin Resistance and Insulin Handling in Chronic Kidney Disease","volume":"13","author":"Parvathareddy","year":"2023","journal-title":"Compr. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hung, K.-C., Yao, W.-C., Liu, Y.-L., Yang, H.-J., Liao, M.-T., Chong, K., Peng, C.-H., and Lu, K.-C. (2023). The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11072076"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wakino, S., Hasegawa, K., Tamaki, M., Minato, M., and Inagaki, T. (2025). Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition. Nutrients, 17.","DOI":"10.3390\/nu17121961"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Barrios, C., Beaumont, M., Pallister, T., Villar, J., Goodrich, J.K., Clark, A., Pascual, J., Ley, R.E., Spector, T.D., and Bell, J.T. (2015). Gut-Microbiota-Metabolite Axis in Early Renal Function Decline. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134311"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic Kidney Disease Alters Intestinal Microbial Flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cozzolino, M., Magagnoli, L., and Ciceri, P. (2025). From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research. Toxins, 17.","DOI":"10.3390\/toxins17060295"},{"key":"ref_19","first-page":"85","article-title":"Trimethylamine N-Oxide and Kidney Diseases: What Do We Know?","volume":"46","author":"Gungor","year":"2024","journal-title":"J. Bras. Nefrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.20456","article-title":"p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease","volume":"25","author":"Lin","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jfda.2018.10.008","article-title":"Measuring Serum Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease Using UPLC-MS\/MS","volume":"27","author":"Lin","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"ref_22","first-page":"938","article-title":"P-Cresyl Sulphate and Indoxyl Sulphate Predict Progression of Chronic Kidney Disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1681\/ASN.0000000000000344","article-title":"The Gut Microbial Metabolite Trimethylamine N-Oxide, Incident CKD, and Kidney Function Decline","volume":"35","author":"Wang","year":"2024","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl Sulfate\u2013Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s40001-025-02824-9","article-title":"The Role of the Gut Microbiota and Its Metabolites: A New Predictor in Diabetes and Its Complications","volume":"30","author":"Wu","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of Diabetic Complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"P-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The Uremic Solutes P-Cresol and Indoxyl Sulfate Inhibit Endothelial Proliferation and Wound Repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"32084","DOI":"10.1038\/srep32084","article-title":"Indoxyl Sulfate Potentiates Skeletal Muscle Atrophy by Inducing the Oxidative Stress-Mediated Expression of Myostatin and Atrogin-1","volume":"6","author":"Enoki","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36618","DOI":"10.1038\/srep36618","article-title":"Metabolic Alterations by Indoxyl Sulfate in Skeletal Muscle Induce Uremic Sarcopenia in Chronic Kidney Disease","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lano, G., Burtey, S., and Sall\u00e9e, M. (2020). Indoxyl Sulfate, a Uremic Endotheliotoxin. Toxins, 12.","DOI":"10.3390\/toxins12040229"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lano, G., Lafor\u00eat, M., Von Kotze, C., Perrin, J., Addi, T., Brunet, P., Poitevin, S., Burtey, S., and Dou, L. (2020). Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072392"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jha, P.K., Nakano, T., Itto, L.Y.U., Barbeiro, M.C., Lupieri, A., Aikawa, E., and Aikawa, M. (2025). Vascular Inflammation in Chronic Kidney Disease: The Role of Uremic Toxins in Macrophage Activation. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1574489"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"RP87316","DOI":"10.7554\/eLife.87316","article-title":"Uremic Toxin Indoxyl Sulfate Induces Trained Immunity via the AhR-Dependent Arachidonic Acid Pathway in End-Stage Renal Disease (ESRD)","volume":"12","author":"Kim","year":"2024","journal-title":"eLife"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ribeiro, A., Liu, F., Srebrzynski, M., Rother, S., Adamowicz, K., Wadowska, M., Steiger, S., Anders, H.-J., Schmaderer, C., and Koziel, J. (2023). Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098031"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2215542","DOI":"10.1080\/07853890.2023.2215542","article-title":"Gut Microbiota-Derived Trimethylamine N-Oxide is Associated with the Risk of All-Cause and Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Dose-Response Meta-Analysis","volume":"55","author":"Li","year":"2023","journal-title":"Ann. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"620826","DOI":"10.1155\/2015\/620826","article-title":"Indoxyl Sulfate-Induced Oxidative Stress, Mitochondrial Dysfunction, and Impaired Biogenesis Are Partly Protected by Vitamin C and N-Acetylcysteine","volume":"2015","author":"Lee","year":"2015","journal-title":"Sci. World J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and Metabolic Disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ki.2014.1","article-title":"Validation of Insulin Sensitivity Surrogate Indices and Prediction of Clinical Outcomes in Individuals with and without Impaired Renal Function","volume":"86","author":"Jia","year":"2014","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/advances\/nmab149","article-title":"Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Chen","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.numecd.2014.04.007","article-title":"Effect of Short-Term Synbiotic Treatment on Plasma P-Cresol Levels in Patients with Chronic Renal Failure: A Randomized Clinical Trial","volume":"24","author":"Guida","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bellasi, A., Di Micco, L., Santoro, D., Marzocco, S., De Simone, E., Cozzolino, M., Di Lullo, L., Guastaferro, P., and Di Iorio, B. (2016). on behalf of UBI Study Investigators. Correction of Metabolic Acidosis Improves Insulin Resistance in Chronic Kidney Disease. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0372-x"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00380-015-0785-7","article-title":"Long-Term Effects of AST-120 on the Progression and Prognosis of Pre-Dialysis Chronic Kidney Disease: A 5-Year Retrospective Study","volume":"31","author":"Sato","year":"2016","journal-title":"Heart Vessels"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD","volume":"26","author":"Schulman","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.CIR.0000050628.11305.30","article-title":"The Antioxidant Acetylcysteine Reduces Cardiovascular Events in Patients With End-Stage Renal Failure: A Randomized, Controlled Trial","volume":"107","author":"Tepel","year":"2003","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Known Knowns and Known Unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/ijem.ijem_237_21","article-title":"Effects of DPP4 Inhibitors on Renal Outcomes in Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"25","author":"Dalui","year":"2021","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","article-title":"Protein-Bound Uremic Toxins, Inflammation and Oxidative Stress: A Cross-Sectional Study in Stage 3\u20134 Chronic Kidney Disease","volume":"45","author":"Rossi","year":"2014","journal-title":"Arch. Med. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The Uremic Toxicity of Indoxyl Sulfate and P-Cresyl Sulfate: A Systematic Review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on Uremic Toxins: Classification, Concentration, and Interindividual Variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Jin, H., Ju, H., Sun, M., Chen, H., and Li, L. (2022). Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.828343"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(99)00069-1","article-title":"Drug Delivery to Mitochondria: The Key to Mitochondrial Medicine","volume":"41","author":"Murphy","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-018-0708-x","article-title":"SGLT2 Inhibition via Dapagliflozin Improves Generalized Vascular Dysfunction and Alters the Gut Microbiota in Type 2 Diabetic Mice","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105816","DOI":"10.1016\/j.isci.2022.105816","article-title":"Integrated Multi-Omics Analyses Reveal Effects of Empagliflozin on Intestinal Homeostasis in High-Fat-Diet Mice","volume":"26","author":"Shi","year":"2023","journal-title":"iScience"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chom.2016.04.017","article-title":"Genetic Determinants of the Gut Microbiome in UK Twins","volume":"19","author":"Goodrich","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment Dominates over Host Genetics in Shaping Human Gut Microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling Type 2 Diabetes and Metformin Treatment Signatures in the Human Gut Microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3472\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:27:48Z","timestamp":1777004868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":64,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083472"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083472","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}